Micrus Endovascular to Present at September Investment Conferences

• Press Release
• Source: Micrus Endovascular Corporation
• On 4:00 am EDT, Thursday September 3, 2009

SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (NASDAQ: MEND - News) today announced that senior management will present at two investment conferences in September:

• Gordon Sangster, Chief Financial Officer, will present at the Baird Health Care Conference on Thursday, September 10, 2009, at 9:00 a.m. Eastern time (6:00 a.m. Pacific time) at the Four Seasons Hotel in New York City, and
• Robert Stern, President and Chief Operating Officer, will present at the UBS Global Life Sciences Conference on Tuesday, September 22, 2009, at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) at the Grand Hyatt Hotel in New York City.

Related Quotes

Symbol	Price	Change
MEND	13.13	-0.43

{"s" : "mend","k" : "c10,l10,p20,t10","o" : "","j" : ""}

Live webcasts of these conference presentations will be available via the Internet by visiting the Investor Relations section of Micrus’ Web site at www.micruscorp.com. An archive of these presentations will be available on the Web site for 14 days.

About Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists, interventional neurologists and neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. Hemorrhagic and ischemic stroke are both significant causes of death and disability worldwide. The Micrus product lines enable physicians to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. Micrus’ proprietary, three-dimensional microcoils anatomically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells stents, balloon catheters, access devices such as guide catheters, microcatheters, guidewires and accessory products used in conjunction with its microcoils. For more information, visit www.micruscorp.com.

Company Contact:
Micrus Endovascular Corporation
Gordon Sangster (gsangster@micruscorp.com)
Vice President, Chief Financial Officer
(408) 433-1400
or
Investor Contacts:
Lippert/Heilshorn & Associates, Inc.
Bruce Voss (bvoss@lhai.com)
Jody Cain (jcain@lhai.com)
(310) 691-7100